Clinical Trials in Los Angeles

Showing 16541-16560 of 16,901 trials

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

NCT00443573

This is a multicenter, two-stage trial with the goal of evaluating up to 100 subjects. This trial will be performed to initiate identification of a safe and effective dose of twice-weekly, subcutaneous rNAPc2 for the second-line treatment of metastatic colorectal carcinoma in combination with contemporary 5-FU-based chemotherapy.

Colon Cancer

ARCA Biopharma, Inc.100 participantsStarted Dec 2006

Los Angeles, California, United States

COMPLETEDPhase 1/2< 1 mile

Study of Individualized Amonafide to Treat Prostate Cancer

NCT00087854

The purpose of this study is to assess the safety and efficacy of Amonafide in men with androgen-independent prostate cancer, assigned to individualized doses of Amonafide based on acetylator phenotype information (doses adjusted on individual metabolism).

Prostate Cancer

Xanthus Pharmaceuticals, Inc.40 participantsStarted Mar 2004

Los Angeles, California, United States • Baltimore, Maryland, United States • St Louis, Missouri, United States +5 more locations

Approved For Marketing< 1 mile

Sapropterin Expanded Access Program

NCT00484991

The Purpose of this study is to provide patients with hyperphenylalaninemia (HPA) due to Phenylketonuria (PKU) access to sapropterin dihydrochloride and to collect more information about the safety of the drug in an expanded access program (EAP) until commercial product is available.

Phenylketonuria

BioMarin Pharmaceutical

Los Angeles, California, United States • Orange, California, United States • San Diego, California, United States +33 more locations

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Study of Individualized Amonafide to Treat Prostate Cancer

Sapropterin Expanded Access Program

Find Trials by Condition in Los Angeles

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Examining the Long-Term Risks of Oophorectomy

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients

Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression

Assess Cancer in Ovarian Tumors With Biomarkers.

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis